中文 EN ລາວ
Browse Products

About Us · About Us

Science-Driven
Patients First

We are an innovation-driven pharmaceutical company committed to bringing breakthrough treatments to patients worldwide through cutting-edge science

Two Decades of Pharmaceutical Innovation
Safeguarding Global Patient Health

Founded in 2006, Poseidon Pharmaceuticals is an R&D-driven innovative pharmaceutical company. Headquartered in Shanghai, we operate 5 R&D centers and 8 manufacturing bases worldwide with over 12,000 employees.

We focus on 10 therapeutic areas with marketed products and 16+ pipeline programs spanning oncology, metabolism, hematology, infectious diseases, antibiotics, inflammation, vaccines, growth hormone, burn care and hormone deficiency.

Guided by our mission of "Scientific Innovation, Safeguarding Life and Health", we continue to invest in R&D and collaborate with leading research institutions to provide high-quality, affordable innovative medicines.

2006
Founded
12,000+
Employees Worldwide
35
Marketed Products

Our Values

The beliefs that guide us forward and form the foundation of every decision we make

Patients First

Patient needs are the starting point of everything we do, always putting patient interests first

Innovation-Driven

Scientific innovation as our core driver, constantly exploring frontier technologies to push medical boundaries

Quality First

Rigorous quality control ensures every medicine is safe, effective and trustworthy

Integrity & Compliance

Upholding ethical standards and legal compliance as responsible corporate citizens

Milestones

Two decades of perseverance, from startup to innovative pharmaceutical leader

2006
Company Founded
Poseidon Pharmaceuticals founded in Shanghai, initially focused on anti-infective R&D and manufacturing
2010
First Product Launched
First antibiotic product approved by NMPA, officially entering the market
2014
Oncology Pipeline
Oncology R&D center established, first targeted anticancer program launched
2017
First mAb Approved
First biosimilar rituximab approved, entering the biologics era
2020
Global Expansion
R&D centers established in the US and Europe, opening a new era of internationalization
2023
Blockbuster Weight-Loss Drug
GIP/GLP-1 dual agonist tirzepatide approved, leading breakthroughs in metabolism
2026
New Innovation Journey
28 marketed products and 16+ pipeline programs, ranking among China's top innovative pharma companies

Contact Us

We look forward to communicating and collaborating with you

Headquarters

Zhangjiang Hi-Tech Park, Pudong New District, Shanghai Poseidon Pharmaceuticals Tower
Postal Code:201203

Customer Service

Hotline:400-888-9999
Hours:Mon-Fri 9:00-18:00
Email:service@Poseidon.com

Business

Business:business@Poseidon.com
Media:pr@Poseidon.com
Careers:hr@Poseidon.com